EMA Redistributes Responsibility For 370 Drugs Currently Overseen By UK

 
• By Ian Schofield

The EMA has completed the reallocation to the EU27 member states of more than 370 centrally authorized drugs for which the UK was rapporteur or co-rapporteur. The move has been necessitated by Brexit, which means the UK will no longer play an active role in new drug evaluations at the EMA.

EU flags
The UK's rapporteurships for centrally authorized drugs are being reallocated to the other EU member states • Source: Shutterstock

More from Europe

More from Geography